Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Amplia opens new front in ovarian cancer fight

Amplia Therapeutics has finalised plans for its PRROSE phase two ovarian cancer trial, with site activation and patient recruitment targeted before year-end.

Amplia opens new front in ovarian cancer fight

We haven't written up this one. The Sydney Morning Herald has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at smh.com.au →

More in Health & Medicine

More from Tuesday 15 September →